FNY Managed Accounts’s AVEO Pharmaceuticals AVEO Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEO
6CM
FNY Managed Accounts's AVEO Position: Q1 2018 in Review
FNY Managed Accounts opened a new position in AVEO Pharmaceuticals (AVEO) in Q1 2018: 50 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #569 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in AVEO as recently as Q1 2015.
FNY Managed Accounts first reported a position in AVEO in Q1 2015 and has held it in 2 quarters since. The position peaked at $18.1K in Q1 2015. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.
- FNY Managed Accounts held 50 shares of AVEO Pharmaceuticals worth $1K as of Q1 2018.
- AVEO Pharmaceuticals was a new FNY Managed Accounts position in Q1 2018.
- AVEO Pharmaceuticals made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #569 holding.
- FNY Managed Accounts first reported a position in AVEO Pharmaceuticals in Q1 2015 and has held it in 2 quarters since.
- FNY Managed Accounts's AVEO Pharmaceuticals position peaked at $18.1K in Q1 2015.
- 90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.